ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa
NCT06214910 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 301
Last updated 2026-01-02
Summary
This study will compare community-delivered, multi-month dispensing of tuberculosis preventive therapy (TPT) to standard-of-care clinic-based TPT delivery in a population of South African adults who are recommended to receive TB preventive therapy.
We hypothesize that persons receiving multi-month dispensing of TPT in the community will have a higher rate of TPT completion at 3 months than persons receiving TPT via standard of care with monthly clinic-based refills.
Conditions
- Tuberculosis
- HIV I Infection
Interventions
- OTHER
-
Community-delivered TB preventive therapy (TPT) - 3 months weekly isoniazid plus rifapentine (3HP)
Participants randomized to this arm will receive the entire supply of TB preventive therapy (TPT) at enrollment.
- OTHER
-
Clinic-link TPT
Participants receive 2-week supply of TPT at initiation, then continue to receive remainder of TPT course at clinic (including refills).
Sponsors & Collaborators
-
Human Sciences Research Council
collaborator OTHER_GOV -
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH - lead OTHER
Principal Investigators
-
Adrienne E Shapiro, MD, PhD · University of Washington
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-20
- Primary Completion
- 2025-05-30
- Completion
- 2025-08-04
Countries
- South Africa
Study Locations
More Related Trials
-
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence
NCT03512249 ·Status: COMPLETED ·Phase: PHASE2
-
The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa
NCT01990274 ·Status: COMPLETED ·Phase: NA
-
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
NCT02410772 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis
NCT06041919 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults
NCT01755598 ·Status: COMPLETED ·Phase: PHASE2
-
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
NCT05007795 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis
NCT04176250 ·Status: COMPLETED ·Phase: PHASE2
-
Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008
NCT06585683 ·Status: COMPLETED
-
Nurse-Led, Symptom-Based Screening of Household Child Contacts of Tuberculosis Index Cases
NCT03074799 ·Status: COMPLETED ·Phase: NA
-
The Correlate of Risk Targeted Intervention Study
NCT02735590 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of Daily Rifapentine for Pulmonary Tuberculosis
NCT00814671 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis
NCT00317330 ·Status: COMPLETED ·Phase: PHASE3
-
Performance Evaluation of TB Breath- and Cough-testing Platforms
NCT03025516 ·Status: UNKNOWN
-
Infant TB Infection Prevention Study
NCT02613169 ·Status: COMPLETED ·Phase: PHASE2
-
Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden
NCT05190146 ·Status: COMPLETED
-
High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
NCT04521803 ·Status: RECRUITING ·Phase: PHASE2
-
Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis
NCT07073638 ·Status: RECRUITING ·Phase: PHASE2
-
Assessing the Ability of the T-SPOT®.TB Test
NCT03929705 ·Status: COMPLETED
-
Choice Architecture Based TB Preventive Therapy Prescribing
NCT04466293 ·Status: COMPLETED ·Phase: NA
-
TB Case-Finding, Treatment and Prevention Intervention in Thailand
NCT05581212 ·Status: COMPLETED ·Phase: NA
-
A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes
NCT02129244 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinic-based Versus Hotspot-focused Active TB Case Finding
NCT05285202 ·Status: RECRUITING ·Phase: NA
-
Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa
NCT02119130 ·Status: COMPLETED ·Phase: NA
-
Same Day Diagnosis of Extrapulmonary TB (TB Serositis and TB Meningitis).
NCT06135818 ·Status: RECRUITING ·Phase: NA
-
Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination
NCT01119521 ·Status: COMPLETED ·Phase: PHASE1